- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Prilosec, Prilosec OTC, OmepraCare, OmepraCare DR
Synonyms :
omeprazole
Class :
Drugs for peptic ulcer & Proton pump inhibitors
gastroesophageal reflux disease (GERD)
20
mg
every day
4
weeks
gastroesophageal reflux disease (GERD)
weight (5-10 kg):
5
mg
orally
every day
weight (10-20 kg): 10 mg orally every day
weight (>20 kg): 20 mg orally every day
antacids may reduce the absorption of quinolones
antacids may reduce the absorption of quinolones
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
antacids: they may diminish the bioavailability of corticosteroids
omeprazole: they may enhance serum concentrations of cilostazol
omeprazole: they may enhance the serum concentration of citalopram
may diminish the bioavailability when combined with corticosteroids
may diminish the bioavailability when combined with corticosteroids
may diminish the bioavailability when combined with corticosteroids
may diminish the bioavailability when combined with corticosteroids
may diminish the bioavailability when combined with corticosteroids
when both drugs are combined, there may be a decrease in levels of serum concentration and absorption of erlotinib
it may reduce the therapeutic effect of bisacodyl
it may decrease the serum concentration of belumosudil
it may decrease the serum concentration of bosutinib
may decrease the serum concentration
may diminish the absorption of iron preparations
may diminish the serum concentration
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may reduce the rate of bioavailability of corticosteroids
may diminish the absorption when combined with quinolones
may diminish the absorption when combined with quinolones
cefuroxime: they may diminish the serum concentration of antacids
chloroquine: they may diminish the serum concentration of antacids
antacids: they may diminish the serum concentration of dabigatran
lanthanum carbonate: they may decrease the therapeutic effect of antacids
ledipasvir: they may diminish the serum concentration of antacids
potassium phosphate: they may diminish the serum concentration of antacids
bosutinib: they may diminish the serum concentration of antacids
dasatinib: they may diminish the serum concentration of antacids
belumosudil: they may diminish the serum concentration of antacids
belumosudil: they may diminish the serum concentration of Inhibitors of the Proton Pump
may decrease the diagnostic effect of each other when combined
omeprazole: they may decrease the antiplatelet effect of clopidogrel
may reduce the time of elimination and increase the serum concentration of methotrexate
may reduce the time of elimination and increase the serum concentration of trimetrexate
CYP2C19 enhancers (moderate) may reduce the therapeutic efficacy of omeprazole
antacids decrease the concentration of cefditoren in serum
they decrease the concentration of rilpivirine in the serum
may decrease the serum concentration
antacids can reduce the amount of cefditoren present in the bloodstream
it may diminish the therapeutic effect of Immune Checkpoint Inhibitors
it may diminish the therapeutic effect of Immune Checkpoint Inhibitors
it may diminish the therapeutic effect of Immune Checkpoint Inhibitors
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the excretion of amphetamines
antacids reduce the systemic absorption of phenothiazine derivatives
antacids reduce the systemic absorption of phenothiazine derivatives
antacids reduce the systemic absorption of phenothiazine derivatives
antacids reduce the systemic absorption of phenothiazine derivatives
antacids reduce the systemic absorption of phenothiazine derivatives
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivative
may diminish the therapeutic effect of bisphosphonate derivative
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
antacids may reduce the absorption of antipsychotic agents
l-methylfolate-pyridoxal 5′-phosphate-methylcobalamine
antacids may reduce the serum concentration of multivitamins
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of bisphosphonate derivatives
may diminish the therapeutic effect of bisphosphonate derivatives
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may decrease the absorption of antipsychotic agents
may diminish the therapeutic effect of immune checkpoint inhibitors
may diminish the therapeutic effect of immune checkpoint inhibitors
may diminish the therapeutic effect of immune checkpoint inhibitors